Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Noe LGA Gesundheit Region Mitte GmbH

Research site

Austria Alter Ziegelweg 10, 3430 Tulln An Der Donau, Austria

  • 1 trial recruiting
  • Pain · Neuropathy peripheral · Back pain
  • Adult patients

About Specializations

Noe LGA Gesundheit Region Mitte GmbH in Tulln An Der Donau, Austria specialises in clinical trials of conditions such as Pain, Neuropathy peripheral, Back pain, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]

The Clinical Department of Neurology at Noe LGA Gesundheit Region Mitte GmbH is conducting focused research on chronic pain associated with various neuropathic conditions and back pain. The trials aim to assess the efficacy and tolerability of the investigational agent AP707 as an add‑on therapy, seeking new options for patients with diabetic polyneuropathy, traumatic or post‑operative peripheral neuropathy, central neuropathy of any origin, and chronic back pain.

  • Efficacy of add‑on therapy
  • Tolerability and safety profiling
  • Neuropathic pain symptom reduction
  • Improvement in functional outcomes

All studies are coordinated by a single investigator at the Tulln‑An‑Der‑Donau site, reflecting a concentrated effort to advance pain management strategies within the European clinical research community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Alter Ziegelweg 103430 Tulln An Der DonauAustria
Open in maps ↗
Recruiting now
1 trial
Conditions studied
5

More sites in Tulln An Der DonauAustria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Crohn's disease

Recruiting

Efficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ORG-129
  • Sponsor:Agomab Spain S.L.U.

Back pain

Not recruiting

Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.